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(41% vs 32%, pcO.01) and non-cardvx vascular disease (38% vs 26%, pcO.001). There 
was no difference between the groups in gender, angina severity, or ejection fraction 
(46%). At completion of treatment most patients, young and old, had angina reduction of 
_> 1 Canadian Cardiovascular Society class with angina episodes and nitoglycerin use 
significantly reduced as well. At one year, 81% reported maintenance of symptom 
improvement and major adverse cardiac event-free survival was comparable in both 
groups (P&86). 
Conclusion: Patients seek medical care to live longer or feel better. EECP offers elderly 
patients, even those with extensive cardiovascular disease, a low-risk intervention that 
significantly reduces angina1 symptoms with cardiac event-free survival comparable to 
younger patients with similar symptoms. 
1162-87 Coronary Interventions in 1,070 Consecutive 
Octogenarians: Complication Rates in Diabetic Versus 
Nondiabetic Patients 
Josef Niebauer, Sebastian Sixt, Fuchun Zhang, Jiangtao Yu. Peter Sick, Holger Thiele. 
Bernward Lauer, Gerhard Schuler. Heart Center University of Leipzig, Leipzig, 
Germany 
Background: Octogenarians with Diabetes mellitus type 2 are perceived as a high risk 
population for procedure-related complications. Since only few studies reported compli- 
cation rates in this population in the era of coronary stenting, we set out to assess their 
risk in a large cohort of patients. 
Methods: We studied 1070 consecutive patients >80 years (82.622.6 year?.; 526 males, 
544 females; 396 with Diabetes (DM). 674 without Diabetes (Non-DM)),who underwent 
cardiac catheterization between January 1995 and July 2000. 
Results: Age (DM: 82.4e2.4 vs. Non-DM: 82.8i2.8 years; p=n.s.) and number of acute 
myocardial infarctions (MI) (DM: 27%, Non-DM: 23%; p=n.s.) were similar in both groups. 
There were more women in the DM (57 %) than in the Non-DM group (44 %; p<O.OOl). 
Diabetics had more 3-vessel disease (DM: 35% vs Non-DM: 29%; ~~0.02); there were 
significantly rnme balloon angioplasties performed in non-diabetic patients (DM: 27% vs 
Non-DM: 43%; pcO.OOl), whereas a higher, but non-significant number of diabetic 
patients underwent bypass surgery (DM: 36% vs Non-DM: 30%; p=O.16). A total of 32 
patients (3%) died (DM: n=6; non-DM: n=26): 5 deaths occured during procedures (3 
patients died during rescue PTCA, 2 during emergency surgery), 16 patients were 
already admitted in cardiogenic shock, 6 died due to complications associated with acute 
myocardial infarctions (e.g. ventricular septal defect), 2 due to decompensated aortic 
stenoses, 2 patrents due to pulmonary embolism, 1 due to aortic dissection type A. At the 
puncture site 39 complications occured (DM 3% vs. non-DM 4%, p=n.s.) 
Conclusions: Despite the notion that it is the diabetic patients among the octogenarians 
who have the highest complication rates, this study shows in a large cohort of patients 
that their complication rates are well comparable to non-diabetic patients, and would thus 
not warrant a more conservative treatment strategy in these patients. 
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Increased Carotid Intimal: Medial Thickness in Elderly 
Postmenopausal Women 
Barlv Ii. McKeown, Richard L. Prince, Amanda Devine, John P. Bellby, Brendan M. 
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Background Little IS known about the relationship between endogenous estrogen and 
atherosclerosis in postmenopausal women. We have examined the association between 
estrogen levels and carotid intimal-medlal thickness (IMT) in a population-based cohort 
study of elderly women who were not taking oral estrogen replacement (Calcium Intake 
fracture Outcome Study - CAIFOS). Methods We assessed 1130 CAIFOS subjects aged 
75.2 +I- 2.7 years (mean+/-standard deviation) at baseline for cardiovascular risk factors 
and estrogen levels and at one year for plasma homocysteine and glycated haemoglo- 
bin. Free Estradiol Index (FE1 - molar ratio of plasma estradiol to sex hormone binding 
globulin x 1000) was used as the measure of endogenous estrogen Three years after 
baseline these wcvnen were assessed for carotid IMT using bilateral carotid B-mode 
ultrasound. Results At baseline 12.2% of these subjects had a history of cardiovascular 
disease (Ischaemic hear? disease, peripheral vascular disease or stroke). Women wth 
greater than the median level of FEI (47.0) had increased mean IMT compared to those 
wth lower levels (0.79mm vs 0.77mm, p=O.O07) The following factors also had a pow 
tive univariate association with IMT; age(p<O.OOOi), pulse pressure (p<O.OOOl). body 
mass index (p=O.Ol), a history of smoking (p=O.Ol) and glycated haemoglobln (p=O.O4). 
In multivariate analysis, the following variables were independently predictive of 
increased IMT; increased pulse pressure (p<O.OOOl). increased age (pcO.OOOl), a his- 
tory of smoking (p=O.O03) and increased FEI (a level greater than the median p=O.O08). 
Conclusion Our study shows that an increased level of endogenous estrogen is predic- 
tive of carotid atherosclerosis and may therefore be important in increasing atheroscle- 
rotic risk in postmenopausal women. 
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844-1 BetaP-Adrenergic Receptor Polymorphisms Predict 
Heart Failure Progression in Idiopathic Dilated 
Cardiomyopathy 
Cinzia Forleo, Nicolena Resta, Sandra Sorrentino, Pi&o Guida, Andrea Manghisi, 
Viviana De Luca, Roberta Romito, Massimo lacoviello, Francesco Massari, Brian Rizzon, 
Ginevra Guanti, Paolo Riuon. Mariavittoria Pitzalis, Bari, Italy 
Background. The stimulation of P2-adrenergic receptor @P-AR) plays a crucial role in 
maintaining catecholamine-mediated inotropism in idiopathic dilated cardiomyopathy 
(DCM). Therefore, P-AR polymorphic variants could influence prognosis in patients with 
DCM. 
Patients and MethodsTo test this hypothesis, we prospectively analysed 160 consecu- 
tive unrelated patients (mean age 49+14 years, 121 males) with DCM (WHO criteria), 
while receiving optimal treatment. All the patients were characterised for the 5’ leader cis- 
tron (SLC)-ArglSCys, ArglGGly, Gln27Glu, and Thrl64lle polymorphisms of the P-AR 
on the basis of PCR amplified DNA using RFLP or SSCP analysis. The progression 
towards HF (worsening in clinical conditions leading to one of the following events: hospi- 
talisation, cardiac transplantation, death) was considered as end point. 
Results. After a median follow-up of 18 months, 11 patients were hospitaksed for con- 
gestive HF, three underwent cardiac transplantation and seven died. Kaplan-Meier sur- 
vival cwves showed that the 5’LC-Arg19/Glu27 haplotype was significantly related to 
events (~~0.05, figure). By Cox multivariate analysis, the 5’LC-Arg19/Glu27 haplotype 
was associated with HF progression (RR=4.09, p<O.Ol), also after adjustment for age, 
NYHA functional class, and left ventricular ejection fraction (RR=4.05, p=O.Oi). 
Conclusions. Among DCM patients, those showing the SLC-Arg19iGlu27 haplotype of 
the@-AR show the worst progresslon of HF at 18 months of follow-up. 
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844-2 Circulating Tumor Necrosis Factor-Alpha and Matrix 
Metalloproteinase Activities in Patients With Idiopathic 
Dilated Cardiomyopathy: Effects of Beta-Blocker on 
Cardiac Matrix Remodeling 
Tomoaki Ohtsuka Mareomi Hamada, Yuji Shigematsu, Yuji Hara, Akiyoshi Ogimoto, 
Tsuyoshi Matsunaka, Jun Suzuki, Katsuji Inoue, Kiyotaka Ohshima, Norikatsu Morioka, 
Akira Kurata, Jitsuo Higaki, Ehime University School of Medicine, Ehime, Japan 
Background: Matrix metalloproteinases (MMPs) contribute to myocardial matrix degrada- 
tion during the remodeling process in the failing heart. Recently, increased myocardial 
MMP activity has been reported to occur in clinical forms of dilated cardiomyopathy. 
Tumor necrosis factor (TNF)-alpha is an important regulator of MMP gene expression. 
This study was designed to clarify the relationship between circulating TNF-alpha and 
MMP activities in patients with idiopathic dilated cardiomyopathy (IDC) and to evaluate 
the effect of beta-blocker on circulating MMP activity in IDC. Methods: We studied 34 
patients with IDC and 10 healthy control subjects. Serum levels of TNF-alpha, MMP-I, 
MMP-3 and MMP-9 were measured using enzyme-linked lmmunosorbent assay. Plasma 
levels of norepinephrine and brain natriuretic peptide (BNP) were also measured. In 20 
patients who had been treated with angiotensin II type 1 receptor blockers, carvedilol 
was administered an addition to the combination therapy. Results: Serum levels of TNF- 
alpha, MMP-1, MMP-3 and MMP-9 were significantly higher in all patients with IDC than 
in control subjects (PC 0.05 for all). There was a significant positive correlation between 
TNF-alpha and MMP-9 levels (r= 0.764, P= 0 01). The MMP-9 levels were also positively 
correlated wth norepinephrine levels (r= 0.750, P= 0.005). In addition, there was a posi- 
tlve correlation between MMP-1 and BNP levels (I= 0.647, P= 0.022) In patients treated 
with carvedilol, the high levels of MMP-1, MMP-9 and TNF-alpha were significantly 
decreased during the treatment (PC 0.05 for all), although MMP-3 levels remained 
unchanged. Conclusion: Circulating TNF-alpha is closely related to MMP activity in IDC 
